GEAN TO 2 — Genetic Analysis As Cashflow Statement
0.000.00%
Last trade - 00:00- NOK23.17m
- NOK19.32m
- NOK11.16m
Annual cashflow statement for Genetic Analysis As, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2018 December 31st | C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | — | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -22.5 | -6.94 | -22.1 | -29 | -28.3 |
| Depreciation | |||||
| Non-Cash Items | 5.32 | 5.11 | 3.3 | -3.15 | 2.73 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.15 | -7.02 | 6.08 | -0.017 | 1.26 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -16.4 | -6.36 | -6.56 | -27.6 | -19.5 |
| Capital Expenditures | -4.86 | -8.23 | -5.18 | -1.95 | -0.227 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 11.6 | — | — | 0.018 | — |
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 6.73 | -8.23 | -5.18 | -1.94 | -0.227 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 7.88 | -1.64 | 31.9 | 52.2 | -1.8 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.81 | -16.2 | 20.2 | 22.6 | -21.5 |